Gan Lin Selected Research

Gan Lin Research Topics

Disease

20	Neoplasms (Cancer) 05/2023 - 02/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2021
2	Infections 11/2023 - 06/2010
2	Inflammation (Inflammations) 11/2023 - 12/2018
2	Breast Neoplasms (Breast Cancer) 05/2023 - 11/2014
2	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2022
1	Chronic Renal Insufficiency 01/2024
1	Wounds and Injuries (Trauma) 11/2023
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Hyperthermia 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Infarction (Infarctions) 01/2019
1	Stroke (Strokes) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Ischemic Stroke 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 02/2008

Drug/Important Bio-Agent (IBA)

4	ferric oxide (iron oxide)IBA 01/2020 - 06/2015
4	Small Interfering RNA (siRNA)IBA 01/2019 - 02/2008
2	Ethiodized Oil (Ethiodol)FDA Link 07/2022 - 01/2022
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2017
2	LigandsIBA 12/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 06/2010
1	16S Ribosomal RNAIBA 01/2024
1	SolutionsIBA 11/2023
1	monooleinIBA 11/2023
1	HydrogelsIBA 11/2023
1	Antimicrobial PeptidesIBA 11/2023
1	CarbenoxoloneIBA 11/2023
1	tributyl phosphate (TBP)IBA 05/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Protein AggregatesIBA 12/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Cadherins (E-Cadherin)IBA 12/2021
1	PaxillinIBA 12/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021
1	mahuang-tangIBA 10/2020
1	CatalaseIBA 10/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2019
1	CXC ChemokinesIBA 01/2019
1	erucylphosphocholineIBA 01/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018
1	PolyestersIBA 02/2018
1	MicellesIBA 02/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2017
1	Metal-Organic FrameworksIBA 01/2017
1	Therapeutic UsesIBA 11/2016
1	Antineoplastic Agents (Antineoplastics)IBA 11/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016
1	Adenosine Triphosphate (ATP)IBA 03/2016
1	CalciumIBA 03/2016
1	MetallothioneinIBA 03/2016
1	VaccinesIBA 07/2015
1	GoldIBA 06/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014

Therapy/Procedure

14	Therapeutics 05/2023 - 02/2008
7	Precision Medicine 10/2020 - 11/2016
5	Drug Therapy (Chemotherapy) 12/2021 - 11/2014
2	Computer-Assisted Surgery (Image Guided Surgery) 07/2022 - 01/2022
2	Immunotherapy 01/2022 - 07/2015
2	Photochemotherapy (Photodynamic Therapy) 05/2018 - 06/2015
1	Surgical Amputation (Amputations) 11/2023
1	Hepatectomy 01/2022
1	Phototherapy (Light Therapy) 05/2018
1	Lasers (Laser) 01/2018
1	Photothermal Therapy 01/2018
1	Radiotherapy 11/2016
1	RNAi Therapeutics 01/2016